SNPHY - Santen Pharmaceutical Co. reports FQ1 results August, 06 2021 06:36 AM Santen Pharmaceutical Co. Ltd. ADR Santen Pharmaceutical Co., Ltd. (OTCPK:SNPHY): FQ1 Non-GAAP EPS of ¥22.56; GAAP EPS of ¥18.44. Revenue of ¥64.98B (+12.9% Y/Y). Press Release For further details see: Santen Pharmaceutical Co. reports FQ1 results